Real-World check: does this psoriasis drug deliver Long-Term relief?

NCT ID NCT04203693

Completed Disease control Sponsor: Almirall, S.A. Source: ClinicalTrials.gov ↗

Summary

This study followed 331 adults with moderate-to-severe plaque psoriasis who were already using or starting the drug tildrakizumab (Ilumetri®) as part of their regular care. The goal was to see how well the treatment worked and how safe it was over nearly two years in a real-world setting, outside of a controlled clinical trial. Researchers tracked skin clearance, quality of life, and side effects to understand the drug's long-term performance in everyday use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site 1

Nice, France
Investigational Site 1

Augsburg, Germany
Investigational Site 1

Arezzo, Italy
Investigational Site 10

Cologne, Germany
Investigational Site 10

Roma, Italy
Investigational Site 11

Lübeck, Germany
Investigational Site 11

Roma, Italy
Investigational Site 12

München, Germany
Investigational Site 12

Rozzano, Italy
Investigational Site 13

Merzig, Germany
Investigational Site 14

Oberursel, Germany
Investigational Site 15

Quedlinburg, Germany
Investigational Site 2

Berlin, Germany
Investigational Site 2

Brescia, Italy
Investigational Site 3

Bochum, Germany
Investigational Site 3

Catania, Italy
Investigational Site 4

Erlangen, Germany
Investigational Site 4

Florence, Italy
Investigational Site 5

Greifswald, Germany
Investigational Site 5

Genova, Italy
Investigational Site 6

Hamburg, Germany
Investigational Site 6

Lecce, Italy
Investigational Site 7

Halle, Germany
Investigational Site 7

Modena, Italy
Investigational Site 8

Kiel, Germany
Investigational Site 8

Roma, Italy
Investigational Site 9

Kiel, Germany
Investigational Site 9

Roma, Italy
Investigational site 1

Breda, Netherlands
Investigator Site 1

Baden, Austria
Investigator Site 1

Brussels, Belgium
Investigator Site 2

Vienna, Austria
Investigator Site 2

Charleroi, Belgium
Investigator Site 2

Poitiers, France
Investigator Site 3

Genk, Belgium
Investigator Site 4

Ghent, Belgium
Investigator Site 5

Herstal, Belgium
Investigator Site 6

Jette, Belgium
Investigator Site 7

Lede, Belgium
Investigator Site 8

Leuven, Belgium
Investigator Site 9

Mons, Belgium

Conditions

Explore the condition pages connected to this study.

PLAQUE PSORIASIS